Observatory · observe first
Johnson & Johnson
JNJ · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
1.829%
12M weight contribution
-0.244 pp
3M weight contribution
-0.266 pp
12M price return
+0.9%
Share of matched S&P 500 members
Monthly observations through Jul 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Jul 2019 | $343.7bn | 1.829% | -0.244 pp | +0.9% | No |
| Jun 2019 | $369.8bn | 1.993% | +0.019 pp | +17.9% | Yes |
| May 2019 | $348.2bn | 2.028% | +0.081 pp | +12.6% | Yes |
| Apr 2019 | $376.0bn | 2.095% | +0.010 pp | +14.7% | Yes |
| Mar 2019 | $372.3bn | 2.139% | +0.029 pp | +12.1% | Yes |
| Feb 2019 | $363.9bn | 2.109% | +0.021 pp | +8.1% | Yes |
| Jan 2019 | $356.9bn | 1.177% | -0.940 pp | -1.1% | No |
| Dec 2018 | $346.1bn | 1.237% | -0.880 pp | -4.1% | No |
| Nov 2018 | $394.0bn | 1.309% | -0.809 pp | +9.2% | No |
| Oct 2018 | $375.4bn | 1.273% | -0.845 pp | +3.4% | No |
| Sep 2018 | $370.7bn | 1.181% | -0.936 pp | +2.0% | No |
| Aug 2018 | $361.3bn | 1.166% | -0.951 pp | -0.5% | No |
| Jul 2018 | $355.4bn | 2.073% | -0.044 pp | -2.8% | Yes |
| Jun 2018 | $325.5bn | 1.975% | -0.143 pp | -11.0% | No |
| May 2018 | $320.8bn | 1.947% | -0.171 pp | -12.2% | No |
| Apr 2018 | $339.4bn | 2.085% | -0.032 pp | -7.9% | No |
| Mar 2018 | $343.8bn | 2.109% | -0.008 pp | -6.7% | Yes |
| Feb 2018 | $348.5bn | 2.088% | -0.029 pp | -5.4% | No |
| Jan 2018 | $371.3bn | 2.118% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.